Skip to main content
. 2019 Sep 6;8(18):e010952. doi: 10.1161/JAHA.118.010952

Figure 3.

Figure 3

FDG quantification and immunosuppression status in cardiac sarcoidosis. A, Normalized maximal standardized uptake valuefor each subject at the time of cardiac sarcoidosis diagnosis and after initial immunosuppression treatment. B, In those subjects who discontinued immunosuppression, normalized maximal standardized uptake value is reported before and after immunosuppression discontinuation. SUV indicates standardized uptake value; SUVmax, maximal standardized uptake value.